NVDA
NVIDIA
-- 144.470 TSLA
Tesla
-- 410.440 CRNC
Cerence
-- 19.330 RGTI
Rigetti Computing
-- 19.0200 RIVN
Rivian Automotive
-- 16.490 
Therapeutics Company Announces Notice of Allowance For Major Patent Over Metabolic Disease Program
BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program.
BioRestorative Therapies, Inc. (BioRestorative or BRTX), a company specializing in stem cell-based therapies, has announced that it received a notice of allowance from the Japanese Patent Office for patent application No. 2021-564135. This patent pertains to the company's allogeneic, off-the-shelf ThermoStem® platform, a crucial aspect of its metabolic disease program. $Biorestorative Therapies (BRTX.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment